$PRLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Prelude Therapeutics Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Prelude Therapeutics Inc. Get notifications about new insider transactions in Prelude Therapeutics Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 31.02 | 23,344 | 724,131 | 23,344 | |
Jun 22 2021 | PRLD | Prelude Therapeuti ... | Dier Mardi | Director | Option Exercise | A | 31.02 | 23,344 | 724,131 | 23,344 | |
Jun 22 2021 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | A | 31.02 | 23,344 | 724,131 | 23,344 | |
May 10 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Option Exercise | M | 1.89 | 15,000 | 28,350 | 212,610 | |
May 10 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 41.07 | 1,109 | 45,545 | 0 | 1.1 K to 0 (-100.00 %) |
May 10 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 40.30 | 10,476 | 422,148 | 1,109 | 11.6 K to 1.1 K (-90.43 %) |
May 10 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 39.36 | 3,415 | 134,399 | 11,585 | 15 K to 11.6 K (-22.77 %) |
May 10 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Buy | M | 1.89 | 15,000 | 28,350 | 15,000 | 0 to 15 K |
Apr 30 2021 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Option Exercise | M | 1.89 | 3,295 | 6,228 | 4,323 | |
Apr 30 2021 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Sell | S | 40.29 | 3,295 | 132,765 | 3,750 | 7 K to 3.8 K (-46.77 %) |
Apr 30 2021 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Buy | M | 1.89 | 3,295 | 6,228 | 7,045 | 3.8 K to 7 K (+87.87 %) |
Apr 30 2021 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Option Exercise | M | 1.89 | 3,223 | 6,091 | 4,323 | |
Apr 30 2021 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Sell | S | 40.29 | 3,223 | 129,853 | 444 | 3.7 K to 444 (-87.89 %) |
Apr 30 2021 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Buy | M | 1.89 | 3,223 | 6,091 | 3,667 | 444 to 3.7 K (+725.90 %) |
Apr 29 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Option Exercise | M | 1.89 | 25,000 | 47,250 | 227,610 | |
Apr 29 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 36.11 | 1,711 | 61,791 | 0 | 1.7 K to 0 (-100.00 %) |
Apr 29 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 35.68 | 15,601 | 556,580 | 1,711 | 17.3 K to 1.7 K (-90.12 %) |
Apr 29 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 34.66 | 7,688 | 266,478 | 17,312 | 25 K to 17.3 K (-30.75 %) |
Apr 29 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Buy | M | 1.89 | 25,000 | 47,250 | 25,000 | 0 to 25 K |
Apr 21 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Option Exercise | M | 1.89 | 25,000 | 47,250 | 252,610 | |
Apr 21 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 31.27 | 4,000 | 125,077 | 0 | 4 K to 0 (-100.00 %) |
Apr 21 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 30.82 | 21,000 | 647,273 | 4,000 | 25 K to 4 K (-84.00 %) |
Apr 21 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Buy | M | 1.89 | 25,000 | 47,250 | 25,000 | 0 to 25 K |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Option Exercise | M | 1.43 | 4,630 | 6,621 | 66,460 | |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Sell | S | 39.57 | 1,669 | 66,040 | 172,920 | 174.6 K to 172.9 K (-0.96 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Sell | S | 38.97 | 669 | 26,073 | 174,589 | 175.3 K to 174.6 K (-0.38 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Sell | S | 37.72 | 875 | 33,003 | 175,258 | 176.1 K to 175.3 K (-0.50 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Sell | S | 36.97 | 1,417 | 52,387 | 176,133 | 177.6 K to 176.1 K (-0.80 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Grant | A | 1.43 | 4,630 | 6,621 | 177,550 | 172.9 K to 177.6 K (+2.68 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Option Exercise | M | 1.89 | 200 | 378 | 7,618 | |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Sell | S | 40.00 | 200 | 8,000 | 3,750 | 4 K to 3.8 K (-5.06 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Grant | A | 1.89 | 200 | 378 | 3,950 | 3.8 K to 4 K (+5.33 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Option Exercise | M | 1.89 | 100 | 189 | 7,546 | |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Sell | S | 40.00 | 100 | 4,000 | 444 | 544 to 444 (-18.38 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Buy | M | 1.89 | 100 | 189 | 544 | 444 to 544 (+22.52 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Option Exercise | M | 1.89 | 9,617 | 18,176 | 277,610 | |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 39.56 | 3,549 | 140,393 | 0 | 3.5 K to 0 (-100.00 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 39.00 | 1,293 | 50,423 | 3,549 | 4.8 K to 3.5 K (-26.70 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 37.83 | 1,501 | 56,780 | 4,842 | 6.3 K to 4.8 K (-23.66 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 37.04 | 3,274 | 121,256 | 6,343 | 9.6 K to 6.3 K (-34.04 %) |
Apr 15 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Buy | M | 1.89 | 9,617 | 18,176 | 9,617 | 0 to 9.6 K |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Option Exercise | M | 1.43 | 15,370 | 21,979 | 71,090 | |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Sell | S | 40.30 | 200 | 8,060 | 172,920 | 173.1 K to 172.9 K (-0.12 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Sell | S | 39.63 | 6,881 | 272,679 | 173,120 | 180 K to 173.1 K (-3.82 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Sell | S | 39.02 | 8,289 | 323,405 | 180,001 | 188.3 K to 180 K (-4.40 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Scherle Peggy | Chief Scientific Of ... | Grant | A | 1.43 | 15,370 | 21,979 | 188,290 | 172.9 K to 188.3 K (+8.89 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Option Exercise | M | 1.89 | 828 | 1,565 | 7,818 | |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Sell | S | 40.08 | 828 | 33,188 | 3,750 | 4.6 K to 3.8 K (-18.09 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Grant | A | 1.89 | 828 | 1,565 | 4,578 | 3.8 K to 4.6 K (+22.08 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Option Exercise | M | 1.89 | 1,000 | 1,890 | 7,646 | |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Sell | S | 40.04 | 1,000 | 40,043 | 444 | 1.4 K to 444 (-69.25 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Buy | M | 1.89 | 1,000 | 1,890 | 1,444 | 444 to 1.4 K (+225.23 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Option Exercise | M | 1.89 | 15,383 | 29,074 | 287,227 | |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 39.69 | 7,083 | 281,116 | 0 | 7.1 K to 0 (-100.00 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Sell | S | 39.03 | 8,300 | 323,908 | 7,083 | 15.4 K to 7.1 K (-53.96 %) |
Apr 09 2021 | PRLD | Prelude Therapeuti ... | Mauro David J | Chief Medical Offic ... | Buy | M | 1.89 | 15,383 | 29,074 | 15,383 | 0 to 15.4 K |
Jan 29 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 12.85 | 5,188 | 66,666 | 41,500 | |
Jan 29 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 12.85 | 5,188 | 66,666 | 41,500 | |
Jan 29 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 12.85 | 5,188 | 66,666 | 9,252,951 | 9.2 M to 9.3 M (+0.06 %) |
Jan 29 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 12.85 | 5,188 | 66,666 | 876,061 | 870.9 K to 876.1 K (+0.60 %) |
Jan 13 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 154,222 | 0 | 5,212,371 | |
Jan 13 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 12,444 | 0 | 509,480 | |
Jan 12 2021 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 41,700 | 0 | 5,596,886 | |
Jan 12 2021 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 41,700 | 0 | 5,596,886 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 152,576 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 295,794 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | P | 0.00 | 76,288 | 0 | 152,576 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 152,576 | 0 | 500,098 | 347.5 K to 500.1 K (+43.90 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 295,794 | 0 | 347,522 | 51.7 K to 347.5 K (+571.83 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 5,555,186 | 0 | 5,555,186 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 413,234 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 619,850 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,945,458 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 4,418,186 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,196,494 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 3,294,743 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 1,033,084 | 0 | 1,033,084 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 3,681,822 | 0 | 7,363,644 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | A | 12.85 | 46,688 | 599,941 | 46,688 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | C | 0.00 | 8,332,779 | 0 | 9,250,191 | 917.4 K to 9.3 M (+908.29 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | P | 19.00 | 710,500 | 13,499,500 | 917,412 | 206.9 K to 917.4 K (+343.38 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | P | 19.00 | 526,300 | 9,999,700 | 526,300 | 0 to 526.3 K |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 152,576 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 295,794 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | P | 0.00 | 76,288 | 0 | 152,576 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 152,576 | 0 | 500,098 | 347.5 K to 500.1 K (+43.90 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 295,794 | 0 | 347,522 | 51.7 K to 347.5 K (+571.83 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 5,555,186 | 0 | 5,555,186 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 413,234 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 619,850 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,945,458 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 4,418,186 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,196,494 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 3,294,743 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 1,033,084 | 0 | 1,033,084 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 3,681,822 | 0 | 7,363,644 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | A | 12.85 | 46,688 | 599,941 | 46,688 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | C | 0.00 | 8,332,779 | 0 | 9,250,191 | 917.4 K to 9.3 M (+908.29 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | P | 19.00 | 710,500 | 13,499,500 | 917,412 | 206.9 K to 917.4 K (+343.38 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | P | 19.00 | 526,300 | 9,999,700 | 526,300 | 0 to 526.3 K |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 382,884 | 0 | 5,058,149 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 382,884 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 30,349 | 0 | 497,036 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 30,349 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 574,327 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 45,524 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 2,698,424 | 0 | 4,675,265 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 2,698,424 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 247,034 | 0 | 466,687 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 247,034 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 4,047,634 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 370,552 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,976,841 | 0 | 1,976,841 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,976,841 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 219,653 | 0 | 219,653 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 219,653 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 2,965,263 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 329,478 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 12.85 | 46,688 | 599,941 | 46,688 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 957,211 | 0 | 957,211 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 75,873 | 0 | 75,873 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 3,373,029 | 0 | 3,373,029 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 308,793 | 0 | 308,793 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 19.00 | 1,474,319 | 28,012,061 | 9,247,763 | 7.8 M to 9.2 M (+18.97 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 19.00 | 104,628 | 1,987,932 | 870,873 | 766.2 K to 870.9 K (+13.65 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 574,327 | 0 | 7,773,444 | 7.2 M to 7.8 M (+7.98 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 45,524 | 0 | 766,245 | 720.7 K to 766.2 K (+6.32 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 4,047,634 | 0 | 7,199,117 | 3.2 M to 7.2 M (+128.44 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 370,552 | 0 | 720,721 | 350.2 K to 720.7 K (+105.82 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 2,965,263 | 0 | 3,151,483 | 186.2 K to 3.2 M (+1,592.34 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 329,478 | 0 | 350,169 | 20.7 K to 350.2 K (+1,592.37 %) |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | Combs Andrew | EVP, Head of Chemis ... | Buy | P | 19.00 | 1,000 | 19,000 | 260,380 | 259.4 K to 260.4 K (+0.39 %) |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 5,555,186 | 0 | 5,555,186 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 413,234 | 0 | 0 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 619,850 | 0 | 0 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,945,458 | 0 | 0 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,418,186 | 0 | 0 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,196,494 | 0 | 0 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,294,743 | 0 | 0 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 8,332,779 | 0 | 9,250,191 | 917.4 K to 9.3 M (+908.29 %) |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 710,500 | 13,499,500 | 917,412 | 206.9 K to 917.4 K (+343.38 %) |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 526,300 | 9,999,700 | 526,300 | 0 to 526.3 K |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | Dier Mardi | Director | Buy | P | 19.00 | 10,000 | 190,000 | 10,000 | 0 to 10 K |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | Morosini Deborah | EVP, Chief of Clini ... | Buy | P | 19.00 | 444 | 8,436 | 444 | 0 to 444 |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | Pierce Christopher | EVP and Chief of Bu ... | Buy | P | 19.00 | 3,750 | 71,250 | 3,750 | 0 to 3.8 K |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | Vaddi Krishna | President, CEO | Option Exercise | C | 0.00 | 32,876 | 0 | 0 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | Vaddi Krishna | President, CEO | Option Exercise | C | 0.00 | 32,876 | 0 | 0 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | Vaddi Krishna | President, CEO | Option Exercise | C | 0.00 | 101,477 | 0 | 0 | |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | Vaddi Krishna | President, CEO | Buy | C | 0.00 | 32,876 | 0 | 551,774 | 518.9 K to 551.8 K (+6.34 %) |
Sep 29 2020 | PRLD | Prelude Therapeuti ... | Vaddi Krishna | President, CEO | Buy | C | 0.00 | 32,876 | 0 | 551,776 | 518.9 K to 551.8 K (+6.34 %) |